TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...

Fluid resuscitation in acute pancreatitis shows crystalloid type and rate interaction influencing hospital length of stay in mild cases.

This list exists because that pattern showed up repeatedly across dozens of services reviewed before these 7 made the cut. Every service ranked here was tested with a real purchase in June 2026.

Truhome’s Rs 3,000 crore IPO brings high leverage, 59% floating-rate debt and peer-low capital adequacy; assess the risks ...

People living with hereditary angioedema, a rare genetic condition that triggers sudden, painful swelling of the face, throat ...

MISSISSAUGA, ON, June 15, 2026 /CNW/ - Chartwell Retirement Residences ("Chartwell") (TSX: CSH.UN) announced today a cash distribution of $0.052 per Trust Unit. The cash distribution will be payable ...

The higher your marginal income tax bracket, the more you need to have a tax-smart investment strategy. Here are some things ...

The bank's new offer tops the market but there are a few catches ...

Following treatment with TG Therapeutics’ Briumvi, patients reported improvements in satisfaction and quality of life.

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

Immigration: Federal immigration officials detained more than 10,000 people in the United States in the five days up to ...

Almost a third of Aussie births in hospitals are now being started through inductions, with experts saying the rise over the ...